No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance

Int J Tuberc Lung Dis. 2016 Feb;20(2):282. doi: 10.5588/ijtld.15.0628.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Fluoroquinolones / therapeutic use*
  • Humans
  • Mycobacterium tuberculosis / drug effects*
  • Pyrazinamide / therapeutic use*
  • Rifampin / therapeutic use*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents
  • Fluoroquinolones
  • Pyrazinamide
  • Rifampin